PremiumCompany AnnouncementsSerina Therapeutics Unveils Breakthrough in POZ-Lipid Technology Serina Therapeutics to present on POZ-lipid technology at ACS Spring 2025 Serina Therapeutics initiated with a Buy at JonesResearch PremiumCompany AnnouncementsSerina Therapeutics Strengthens Board with New Appointment Serina Therapeutics Announces SER-252 for Parkinson’s Trials Serina Therapeutics Updates Equity Plan and Elects Directors PremiumThe FlySerina Therapeutics Inc trading halted, volatility trading pause Serina Therapeutics CDO Presents at Injectables Summit Serina Therapeutics Names Steven Ledger as Permanent CEO